Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer.

Yoshifumi Nakayama, Yuzuru Inoue, Noritaka Minagawa, Takefumi Katsuki, Nobuo Nagashima, Koji Onitsuka, Yosuke Tsurudome, Tatsuhiko Sako, Keiji Hirata, Naoki Nagata,

PubMed · 2004 · 29 citations · 14 references

Concepts

Abstract

BACKGROUND: An increased number of dendritic cells (DCs), as indicated by positive S-100 protein staining, has been shown to correlate with good prognosis in several malignancies. The clinicopathological significance of S-100 protein-positive cells in human colorectal cancer is unclear and was thus examined. PATIENTS AND METHODS: We investigated the relationships between the density of S-100 protein-positive cells at the peripheral area of the tumor, prognosis and clinicopathological factors in 30 patients with colorectal cancer. S-100 protein-positive cells were detected by immunohistochemistry using a mouse monoclonal antibody against S-100 protein. RESULTS: The number of S-100 protein-positive cells was significantly higher in patients with a good prognosis or those without recurrence or worsening of their condition, but was significantly lower in patients with lymph node metastasis, T3-T4, hepatic metastasis or tumors more advanced than stage III (TNM). CONCLUSION: S-100 protein-positive cells may act as one line of defense against malignant cells in patients with colorectal cancer.

References

14